Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,182Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M6.1EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)19.0Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.7PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17,550,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PJP

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

PJP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PJP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Honig, BarryDirector 2016-07-08Buy20,000$0.3121480.65view
Nadeau, SteveSenior Officer 2016-07-08Buy4,500$1.245295.16view
haukedal, peter lawrence10% Security Holder 2016-07-08Buy41,000$0.0795471.43view
haukedal, peter lawrence10% Security Holder 2016-07-08Buy9,000$0.0795471.43view
Roodenburg, Anthony RalphDirector, Senior Officer 2016-07-08Buy100,000$0.1544500view
Churcher, Dale LeeworthySenior Officer 2016-07-08Sell39,377$6.55921.37view
Sanderson, Robert KeithDirector 2016-07-08Buy15,000$0.04167150view
International Finance Corporat10% Security Holder 2016-07-08Sell1,000,000$0.05133700view
Meade, Harlan DonnleyDirector, Senior Officer 2016-07-08Buy1,500$0.1641712.5view
Meade, Harlan DonnleyDirector, Senior Officer 2016-07-08Buy4,000$0.1837066.67view

Quarterly/Annual Reports about PJP:

    News about PJP:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Bristol-Myers Squibb’s 2Q16 Estimates: Expect Growth! Jul 25 2016
    How Did JNJ’s Medical Devices Segment Perform in 2Q16? Jul 25 2016
    A Consumer Staples ETF To Feast On Jul 25 2016
    Restaurants Reflect Consumption Trends (Literally) Jul 23 2016
    Why Does Ligand Pharmaceuticals Have Such an Attractive Margin? Jul 20 2016
    What Lilly Expects for Revenue Growth in 2Q16 Jul 19 2016
    Ligand Pharmaceuticals’s Portfolio Pyramid as Its Valuation Catalyst Jul 18 2016
    Why Are So Many Analysts Rating B&G Foods a ‘Hold’? Jul 12 2016
    Why Did Cal-Maine Shares Fall 23% in the Last 3 Months? Jun 29 2016
    Mylan’s Profits: Can You Expect Changes? Jun 28 2016
    Why Is Mylan’s Valuation so Low? Our Diagnosis Jun 24 2016
    Hain Celestial Traded above Key Moving Averages May 11 2016
    Mudslinging Over Valeant Pharmaceuticals May 07 2016
    Trending on ETFdb.com: Central Bank Inaction Moves Markets May 05 2016
    Finding Pharmaceuticals ETFs With Rebound Potential May 04 2016
    How Did Eli Lilly’s 1Q16 Business Segment Perform? Apr 29 2016
    Potent Value In This Large-Cap ETF Mar 18 2016
    Can Trump make your stock portfolio great again? Mar 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)